Document is current
Any future updates will be listed below
-
Authors
Shore, Neal D. https://orcid.org/0000-0001-5767-0548
Pieczonka, Christopher M. https://orcid.org/0000-0002-2531-7587
Heron, Sean
Gazi, Mukaram
Cahn, David J.
Belkoff, Laurence H.
Berger, Aaron D.
Mazzarella, Brian
Veys, Joseph
Morris, David https://orcid.org/0000-0001-9054-6899
Bevan-Thomas, Richard
Engelman, Alexander
Dato, Paul
Wise, David R. https://orcid.org/0000-0003-3419-4723
Hardwick, Mary Kay
Aradhya, Kerry W.
Heald, Brandie https://orcid.org/0000-0003-4227-3675
Nussbaum, Robert L.
Hatchell, Kathryn E. https://orcid.org/0000-0003-0849-7018
Bucknor, Brianna
Esplin, Edward D. https://orcid.org/0000-0001-9205-3756
Nielsen, Sarah M.
-
Funding
Funding for this research was provided by:
Invitae Corp
- License Information
-
More Information
Article History
Received: 19 February 2025
Revised: 28 July 2025
Accepted: 13 August 2025
First Online: 22 September 2025
Ethics approval and consent to participate
: Ethics approval for PROCLAIM was approved by WCG IRB (Puyallup, WA; protocol 20191596). All patients provided informed consent to have their de-identified data used in this study. This study was performed in accordance with the Declaration of Helsinki.
: NS is a consultant or advisor for AbbVie, Amgen, Astellas Pharma, AstraZeneca, Bayer, Bristol Myers Squibb, Boston Scientific, Clovis Oncology, Cold Genesys, Dendreon, EMD Serono, Merck, Exact Imaging, Exact Sciences, FerGene, Foundation Medicine, GConcology, Genentech, GenesisCare, Genomic Health, Guardant Health, Invitae, Janssen, MDxHealth, Merck, Moivant, Myriad Genetics, Nymox, Pacific Edge, Phosphorus, Pfizer, Propella, Sanofi Genzyme, Sesen Bio, Tolmar, and UroGen Pharma. CMP has received research funding from Astellas Pharma, AstraZeneca, Bayer, Dendreon, Eli Lilly, Invitae, Janssen, Merck, Myovant Sciences, Myriad Genetics, Pfizer, and Veru, and is a consultant for Astellas Pharma, AstraZeneca, Bayer, Dendreon, Foundation Medicine, Janssen, Large Urology Group Practice Association, Merck, Myovant Sciences, Pfizer, Sun, and UroGPO. DJC is a consultant for Janssen and AstraZeneca. LHB is a consultant for Marius Pharmaceuticals. ADB is a speaker for Astellas Pharma, Janssen, Myovant Sciences, and Pfizer. BM is a consultant for NeoTract/Teleflex, Calyxo, MagForce USA, and UroDev Medical, and is Medical Director and an equity holder for Convergent Genomics. DM is a consultant for Astellas Pharma, AstraZeneca, Clovis Oncology, Decipher, Janssen, and Myriad Genetics. AE is a consultant for Myriad Genetics and an investigator for Palette Life Sciences. PD is a speaker for Astellas Pharma, Bayer, Dendreon, Exact Imaging, Janssen, Myovant, and Pfizer; and a consultant for Dendreon, Exact Imaging, and Myovant. DRW is a consultant for Foundation Medicine, Janssen, Labcorp, Leap Therapeutics, Myovant, and Pfizer. KWA, BH, KEH, and RLN were employees of Invitae Corp., now part of Labcorp. BB, EDE, and SMN are current employees of Labcorp. EDE is an advisor and stockholder of Taproot Health, Exir Bio, and ROMTech.
